Book TB PCR Test in Madurai

The TB PCR test is a molecular diagnostic test that detects the genetic material of Mycobacterium tuberculosis, the bacterium responsible for tuberculosis, using polymerase chain reaction technology. PCR amplifies specific DNA sequences unique to the TB bacterium from a patient sample, enabling detection of even minute quantities of bacterial genetic material with high sensitivity and specificity. Unlike conventional TB diagnosis which relies on sputum smear microscopy or culture methods that take weeks to yield results, the TB PCR test delivers a clinically actionable answer within 24 to 48 hours, fundamentally transforming the speed at which TB diagnosis and treatment initiation can occur. TB PCR differs from the GeneXpert MTB/RIF assay in that it is a broader molecular platform applicable to a wider variety of clinical specimens including blood, urine, cerebrospinal fluid, pleural fluid, synovial fluid, lymph node aspirates, and tissue biopsies, making it particularly valuable for diagnosing extrapulmonary tuberculosis where sputum-based tests are not applicable. The test can also be customised to detect drug resistance mutations beyond rifampicin, including isoniazid, fluoroquinolones, and second-line injectable agents, providing a more comprehensive resistance profile in complex drug-resistant TB cases. India carries the highest TB burden globally, accounting for approximately 27 percent of all new TB cases worldwide according to WHO data. Despite national elimination targets, TB remains a leading infectious cause of mortality in India, with extrapulmonary TB accounting for approximately 15 to 20 percent of all cases and presenting diagnostic challenges where conventional methods frequently fail. The TB PCR test addresses these gaps directly. The test is performed on an appropriate clinical specimen collected by a healthcare professional.

Doctors prescribe a TB PCR test in the following situations: Diagnosing pulmonary tuberculosis rapidly in patients with chronic productive cough, haemoptysis, weight loss, night sweats, and fever where molecular confirmation within 24 to 48 hours enables immediate treatment initiation and isolation precautions, reducing community transmission and preventing diagnostic delay. Investigating extrapulmonary tuberculosis including TB meningitis, pleural TB, spinal TB, TB lymphadenitis, renal TB, and pericardial TB where sputum-based tests are inapplicable and PCR applied to the relevant clinical specimen such as CSF, pleural fluid, or tissue biopsy provides rapid molecular confirmation that is otherwise unachievable with conventional methods. Evaluating smear-negative pulmonary TB in patients with strong clinical and radiological suspicion of TB but repeatedly negative sputum smear microscopy, where PCR significantly improves diagnostic sensitivity and enables confirmation in paucibacillary cases that smear microscopy routinely misses. Diagnosing TB in HIV-positive patients where clinical presentation is atypical, sputum smear sensitivity is markedly reduced due to low bacterial loads, and rapid molecular diagnosis is critical given the high mortality of untreated TB-HIV coinfection and the urgency of concurrent antiretroviral and anti-TB therapy initiation. Detecting drug-resistant tuberculosis in patients with treatment failure, relapse, or prior exposure to anti-TB drugs where PCR-based resistance profiling identifies specific resistance mutations guiding individualised second-line drug regimen construction under specialist supervision. Investigating unexplained fever of unknown origin, lymphadenopathy, and pleural or pericardial effusions in clinical settings where TB is part of the differential diagnosis and rapid molecular testing of appropriate specimens provides definitive diagnostic clarity more efficiently than empirical treatment trials.

The TB PCR test detects the presence or absence of Mycobacterium tuberculosis DNA in the tested specimen through molecular amplification. Results are reported qualitatively rather than as a numerical value, with some platforms also providing semi-quantitative bacterial load information. TB DNA Not Detected A not detected result indicates that Mycobacterium tuberculosis DNA was not identified in the specimen tested. This effectively rules out TB in the tested sample with high confidence, though a single negative result in a patient with strong clinical and radiological suspicion does not entirely exclude TB, particularly in paucibacillary extrapulmonary disease where bacterial load in the specimen may fall below the detection threshold. TB DNA Detected, Drug Sensitive This result confirms the presence of Mycobacterium tuberculosis DNA and indicates sensitivity to tested anti-TB drugs, meaning standard first-line treatment under the National TB Elimination Programme is appropriate. Prompt notification to the treating physician enables immediate treatment initiation and contact tracing as per NTEP guidelines. TB DNA Detected, Drug Resistant This result confirms TB and identifies resistance to one or more anti-TB drugs through detection of specific resistance-associated gene mutations. This finding requires immediate referral to a drug-resistant TB treatment centre, initiation of an appropriate second-line regimen under specialist supervision, and mandatory notification to the national TB programme as per regulatory requirements.

Preparation for the TB PCR test depends entirely on the type of specimen being collected, as this test is performed on multiple specimen types depending on the clinically suspected site of TB infection. For sputum-based TB PCR, patients should provide a deep cough early morning sputum specimen before eating or drinking, rinsing the mouth with plain water beforehand without using toothpaste or mouthwash, which can inhibit the PCR reaction and reduce sensitivity. For blood-based TB PCR, no fasting is required and the test can be performed at any time of day. For other specimens including cerebrospinal fluid, pleural fluid, urine, or tissue biopsies, collection is performed by a healthcare professional under appropriate clinical conditions and patients should follow specific pre-procedure instructions provided by their treating physician for each specimen type. Inform your doctor if you are already receiving anti-TB medications before the test, as prior antibiotic exposure can reduce bacterial load in specimens and may affect detection sensitivity in some cases. Prompt transport of collected specimens to the laboratory is essential for preserving nucleic acid integrity, and if any delay is anticipated, specimens should be stored at 2 to 8 degrees Celsius. Staying well hydrated before a blood draw facilitates easier venous access if blood is the specimen type being collected.

If you are booking through the SecondMedic platform the TB PCR test price in Madurai can cost you around Rs. 1925. You may also consider booking a comprehensive TB diagnostic panel that includes TB PCR alongside chest X-ray, ESR, complete blood count, and LFT for a thorough tuberculosis workup at a bundled price on SecondMedic.

SecondMedic offers convenient home sample collection for the TB PCR test in Madurai, making it easy to get tested without visiting a diagnostic centre. Home collection is available free of charge for orders above Rs. 300. A trained professional will visit your preferred address between 7 AM and 10 PM, seven days a week, including Sundays and public holidays. Your sample is processed at NABL-accredited partner laboratories, and your report is delivered within 24 hours directly to your WhatsApp and email.